Cannabis Investor Briefing

Federal Landscape

DEA Schedule III NPRM status, SAFE Banking Act prospects, IRS/280E enforcement posture, and Congressional activity since last quarter.

State Regulatory Shifts

New market openings, license application windows, social equity program updates, and enforcement pattern changes in 12 priority states.

M&A Activity Review

Q-over-Q deal flow analysis, valuation multiples, license-transfer mechanics, distressed asset opportunities, and notable transactions.

Tax & Banking Update

§471(c) safe harbor litigation, IRC §280E successor liability in M&A, FinCEN guidance evolution, and payment rails landscape.

Live Q&A with Bob Hoban

Direct access to Bob for 15 minutes. Submit questions in advance at registration or ask live during the session.

Pre-Briefing Packet

PDF distributed 24 hours before each session: key exhibits, data tables, and regulatory citations referenced in the briefing.

Recording + Transcript

Full recording and transcript delivered to all registered seats within 48 hours of the session.

Robert Hoban, Esq.

Twenty years at the intersection of cannabis law, regulatory strategy, and capital markets. Bob Hoban has advised cannabis-focused investors, M&A buyers, and public companies across 30+ jurisdictions on federal rescheduling, §280E tax exposure, license-transfer mechanics, and multi-state operator diligence.

He has served as general counsel, outside M&A advisor, and regulatory expert witness in cannabis deal rooms from seed-stage licensing to nine-figure acquisitions. The quarterly Investor Briefing distills that deal-floor intelligence into a structured session designed for funds — not operators.

Prior briefing topics have included